Lawlor Debbie A, Harbord Roger M, Timpson Nic J, Lowe Gordon D O, Rumley Ann, Gaunt Tom R, Baker Ian, Yarnell John W G, Kivimäki Mika, Kumari Meena, Norman Paul E, Jamrozik Konrad, Hankey Graeme J, Almeida Osvaldo P, Flicker Leon, Warrington Nicole, Marmot Michael G, Ben-Shlomo Yoav, Palmer Lyle J, Day Ian N M, Ebrahim Shah, Smith George Davey
MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Bristol, United Kingdom.
PLoS One. 2008 Aug 20;3(8):e3011. doi: 10.1371/journal.pone.0003011.
It is unclear whether C-reactive protein (CRP) is causally related to coronary heart disease (CHD). Genetic variants that are known to be associated with CRP levels can be used to provide causal inference of the effect of CRP on CHD. Our objective was to examine the association between CRP genetic variant +1444C>T (rs1130864) and CHD risk in the largest study to date of this association.
We estimated the association of CRP genetic variant +1444C>T (rs1130864) with CRP levels and with CHD in five studies and then pooled these analyses (N = 18,637 participants amongst whom there were 4,610 cases). CRP was associated with potential confounding factors (socioeconomic position, physical activity, smoking and body mass) whereas genotype (rs1130864) was not associated with these confounders. The pooled odds ratio of CHD per doubling of circulating CRP level after adjustment for age and sex was 1.13 (95%CI: 1.06, 1.21), and after further adjustment for confounding factors it was 1.07 (95%CI: 1.02, 1.13). Genotype (rs1130864) was associated with circulating CRP; the pooled ratio of geometric means of CRP level among individuals with the TT genotype compared to those with the CT/CC genotype was 1.21 (95%CI: 1.15, 1.28) and the pooled ratio of geometric means of CRP level per additional T allele was 1.14 (95%CI: 1.11, 1.18), with no strong evidence in either analyses of between study heterogeneity (I(2) = 0%, p>0.9 for both analyses). There was no association of genotype (rs1130864) with CHD: pooled odds ratio 1.01 (95%CI: 0.88, 1.16) comparing individuals with TT genotype to those with CT/CC genotype and 0.96 (95%CI: 0.90, 1.03) per additional T allele (I(2)<7.5%, p>0.6 for both meta-analyses). An instrumental variables analysis (in which the proportion of CRP levels explained by rs1130864 was related to CHD) suggested that circulating CRP was not associated with CHD: the odds ratio for a doubling of CRP level was 1.04 (95%CI: 0.61, 1.80).
We found no association of a genetic variant, which is known to be related to CRP levels, (rs1130864) and having CHD. These findings do not support a causal association between circulating CRP and CHD risk, but very large, extended, genetic association studies would be required to rule this out.
目前尚不清楚C反应蛋白(CRP)与冠心病(CHD)之间是否存在因果关系。已知与CRP水平相关的基因变异可用于推断CRP对CHD的影响。我们的目的是在迄今为止关于此关联的最大规模研究中,检验CRP基因变异+1444C>T(rs1130864)与CHD风险之间的关联。
我们在五项研究中估计了CRP基因变异+1444C>T(rs1130864)与CRP水平以及与CHD的关联,然后汇总这些分析(N = 18637名参与者,其中4610例为病例)。CRP与潜在混杂因素(社会经济地位、体力活动、吸烟和体重)相关,而基因型(rs1130864)与这些混杂因素无关。在调整年龄和性别后,循环CRP水平每翻倍,CHD的汇总比值比为1.13(95%CI:1.06,1.21),在进一步调整混杂因素后为1.07(95%CI:1.02,1.13)。基因型(rs1130864)与循环CRP相关;TT基因型个体与CT/CC基因型个体相比,CRP水平几何均值的汇总比值为1.21(95%CI:1.15,1.28),每增加一个T等位基因,CRP水平几何均值的汇总比值为1.14(95%CI:1.11,1.18),两项分析均无强有力的证据表明研究间存在异质性(两项分析的I² = 0%,p>0.9)。基因型(rs1130864)与CHD无关联:将TT基因型个体与CT/CC基因型个体相比,汇总比值比为1.01(95%CI:0.88,1.16),每增加一个T等位基因的汇总比值比为0.96(95%CI:0.90,1.03)(两项荟萃分析的I²<7.5%,p>0.6)。一项工具变量分析(其中rs1130864解释的CRP水平比例与CHD相关)表明,循环CRP与CHD无关联:CRP水平翻倍的比值比为1.04(95%CI:0.61,1.80)。
我们发现已知与CRP水平相关的基因变异(rs1130864)与患CHD无关联。这些发现不支持循环CRP与CHD风险之间存在因果关联,但需要非常大规模、扩展的基因关联研究来排除这一点。